Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 137

Similar articles for PubMed (Select 21792213)

1.

Dietary intake associated with serum versus urinary carboxymethyl-lysine, a major advanced glycation end product, in adults: the Energetics Study.

Semba RD, Ang A, Talegawkar S, Crasto C, Dalal M, Jardack P, Traber MG, Ferrucci L, Arab L.

Eur J Clin Nutr. 2012 Jan;66(1):3-9. doi: 10.1038/ejcn.2011.139. Epub 2011 Jul 27.

2.

Circulating levels and dietary intake of the advanced glycation end-product marker carboxymethyl lysine in chronic kidney disease patients on conservative predialysis therapy: a pilot study.

Piroddi M, Palazzetti I, Quintaliani G, Pilolli F, Montaldi M, Valentina V, Libetta C, Galli F.

J Ren Nutr. 2011 Jul;21(4):329-39. doi: 10.1053/j.jrn.2010.06.024. Epub 2010 Dec 30.

PMID:
21193322
3.

Metabolic transit of N(ε)-carboxymethyl-lysine after consumption of AGEs from bread crust.

Roncero-Ramos I, Delgado-Andrade C, Tessier FJ, Niquet-Léridon C, Strauch C, Monnier VM, Navarro MP.

Food Funct. 2013 Jul;4(7):1032-9. doi: 10.1039/c3fo30351a. Epub 2013 Feb 25.

PMID:
23435675
4.

Fat mass is inversely associated with serum carboxymethyl-lysine, an advanced glycation end product, in adults.

Semba RD, Arab L, Sun K, Nicklett EJ, Ferrucci L.

J Nutr. 2011 Sep;141(9):1726-30. doi: 10.3945/jn.111.143172. Epub 2011 Jul 20.

5.

Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients.

Uribarri J, Peppa M, Cai W, Goldberg T, Lu M, Baliga S, Vassalotti JA, Vlassara H.

Am J Kidney Dis. 2003 Sep;42(3):532-8.

PMID:
12955681
6.

Dietary intake of advanced glycation end products did not affect endothelial function and inflammation in healthy adults in a randomized controlled trial.

Semba RD, Gebauer SK, Baer DJ, Sun K, Turner R, Silber HA, Talegawkar S, Ferrucci L, Novotny JA.

J Nutr. 2014 Jul;144(7):1037-42. doi: 10.3945/jn.113.189480. Epub 2014 Apr 17.

7.

Fluorescent serum and urinary advanced glycoxidation end-products in non- diabetic subjects.

Maza MP, Bravo A, Leiva L, Gattás V, Petermann M, Garrido F, Bunout D, Hirsch S, Barrera G, Fernández M.

Biol Res. 2007;40(2):203-12. Epub 2007 Nov 21.

8.
10.

Dietary intake increases serum levels of carboxymethil-lysine (CML) in diabetic patients.

Jara N, Leal MJ, Bunout D, Hirsch S, Barrera G, Leiva L, de la Maza MP.

Nutr Hosp. 2012 Jul-Aug;27(4):1272-8. doi: 10.3305/nh.2012.27.4.5861.

11.

Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes.

Miura J, Yamagishi Si, Uchigata Y, Takeuchi M, Yamamoto H, Makita Z, Iwamoto Y.

J Diabetes Complications. 2003 Jan-Feb;17(1):16-21.

PMID:
12505751
12.

The advanced glycation end product Nepsilon-(carboxymethyl)lysine is increased in serum from children and adolescents with type 1 diabetes.

Berg TJ, Clausen JT, Torjesen PA, Dahl-Jørgensen K, Bangstad HJ, Hanssen KF.

Diabetes Care. 1998 Nov;21(11):1997-2002.

PMID:
9802757
13.

N(epsilon)-(carboxymethyl)lysine levels in patients with type 2 diabetes: role of renal function.

Wagner Z, Wittmann I, Mazák I, Schinzel R, Heidland A, Kientsch-Engel R, Nagy J.

Am J Kidney Dis. 2001 Oct;38(4):785-91.

PMID:
11576882
14.

Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging.

Uribarri J, Cai W, Peppa M, Goodman S, Ferrucci L, Striker G, Vlassara H.

J Gerontol A Biol Sci Med Sci. 2007 Apr;62(4):427-33.

15.

Dietary consumption of advanced glycation end products and pancreatic cancer in the prospective NIH-AARP Diet and Health Study.

Jiao L, Stolzenberg-Solomon R, Zimmerman TP, Duan Z, Chen L, Kahle L, Risch A, Subar AF, Cross AJ, Hollenbeck A, Vlassara H, Striker G, Sinha R.

Am J Clin Nutr. 2015 Jan;101(1):126-34. doi: 10.3945/ajcn.114.098061. Epub 2014 Nov 19.

PMID:
25527756
16.

An inhibitor of advanced glycation end product formation reduces N epsilon-(carboxymethyl)lysine accumulation in glomeruli of diabetic rats.

Nakamura S, Tachikawa T, Tobita K, Aoyama I, Takayama F, Enomoto A, Niwa T.

Am J Kidney Dis. 2003 Mar;41(3 Suppl 1):S68-71.

PMID:
12612956
17.

Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease.

Kilhovd BK, Berg TJ, Birkeland KI, Thorsby P, Hanssen KF.

Diabetes Care. 1999 Sep;22(9):1543-8.

18.

N(carboxymethyl)lysine as a biomarker for microvascular complications in type 2 diabetic patients.

Wautier MP, Massin P, Guillausseau PJ, Huijberts M, Levy B, Boulanger E, Laloi-Michelin M, Wautier JL.

Diabetes Metab. 2003 Feb;29(1):44-52.

19.

Serum carboxymethyl-lysine, a dominant advanced glycation end product, is associated with chronic kidney disease: the Baltimore longitudinal study of aging.

Semba RD, Fink JC, Sun K, Windham BG, Ferrucci L.

J Ren Nutr. 2010 Mar;20(2):74-81. doi: 10.1053/j.jrn.2009.08.001. Epub 2009 Oct 22.

20.

Serum carboxymethyl-lysine, an advanced glycation end product, is associated with increased aortic pulse wave velocity in adults.

Semba RD, Najjar SS, Sun K, Lakatta EG, Ferrucci L.

Am J Hypertens. 2009 Jan;22(1):74-9. doi: 10.1038/ajh.2008.320. Epub 2008 Nov 20.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk